Ventricular-vascular coupling is predictive of adverse clinical outcome in paediatric pulmonary arterial hypertension

Melanie J Dufva1,2,3, Dunbar Ivy2,3, Kristen Campbell2,3

  • 1Bioengineering, University of Colorado Denver - Anschutz Medical Campus, Aurora, Colorado, USA melanie.dufva@cuanschutz.edu.

Open Heart
|September 29, 2021
PubMed

Insights

Ventricular-vascular coupling (Ees/Ea) derived from right ventricular pressure alone predicts adverse outcomes in pediatric pulmonary arterial hypertension (PAH). This metric shows prognostic capacity, especially in idiopathic/hereditary PAH, aiding clinical management.

Area of Science:

  • Cardiology
  • Pediatric Pulmonology
  • Hemodynamics

Background:

  • Ventricular-vascular coupling (Ees/Ea) is a key hemodynamic metric.
  • Pulmonary arterial hypertension (PAH) in children requires effective prognostic tools.
  • Assessing Ees/Ea using only right ventricular pressure could simplify prognostic evaluation in pediatric PAH.

Purpose of the Study:

  • To evaluate the prognostic capability of the ventricular-vascular coupling ratio (Ees/Ea) in pediatric patients with PAH.
  • To determine if Ees/Ea, calculated solely from right ventricular pressure, can predict clinical outcomes.
  • To compare the prognostic value of Ees/Ea in different subtypes of pediatric PAH (IPAH/HPAH vs. APAH).

Main Methods:

  • Retrospective review of 130 pediatric PAH patients diagnosed via right heart catheterization.
  • Calculation of Ees/Ea using two single-beat methods (Takeuchi and Kind) based on right ventricular pressure.
  • Cox proportional hazard modeling to assess the association between Ees/Ea and time to clinical events (soft and hard).

Main Results:

  • In idiopathic/hereditary PAH (IPAH/HPAH), both Ees/Ea_Kind and Ees/Ea_Takeuchi were independently associated with time to hard adverse events, even after adjusting for indexed pulmonary vascular resistance.
  • Neither Ees/Ea method was associated with time to soft adverse events in IPAH/HPAH patients.
  • In associated PAH (APAH) patients, Ees/Ea did not show a significant association with either hard or soft adverse events.

Conclusions:

  • Ventricular-vascular coupling (Ees/Ea) derived from pressure alone is a potent independent predictor of adverse outcomes in pediatric PAH.
  • This pressure-derived Ees/Ea ratio holds potential as a valuable prognostic tool for managing children with PAH.
  • The prognostic utility of Ees/Ea appears more pronounced in IPAH/HPAH compared to APAH.
Abstract

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
332
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
104
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
83